View the RESPICARE 10 MG registration information details.
Back to drug list
ItemsDrug Registration information
ID2870
No2870
Brand NameRESPICARE 10 MG
IngredientsMONTELUKAST SODIUM 10 MG
Dosage FormTABLET
Primary PackagingALU-ALU
Storage
Shelf Life2 YEARS
Pack Size2 X 7'S/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsPROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA INCLUDING: THE PREVENTION OF DAY TIME AND NIGHT TIME SYMPTOMS, THE PREVENTION OF EXERCISED-INDUCED BRONCHOCONSTRICTION, ALSO RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE OR OLDER
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionSQUARE, VIOLET, BICONVEX, COATED TABLET, ENGRAVED GENIX ON ONE SIDE AND PLAIN ON THE OTHER SIDE
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerGENIX PHARMA(PRIVATE) LTD.
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 I 4372/18
FDD Registration Date28/03/2025
Expiry Date27/03/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA